SA

Sarfraj Ahmad

Active Director Director DIN 10862077
DIN 10862077 First appointment Dec 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Dec 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sarfraj Ahmad

Data last updated:

Sarfraj Ahmad is a Director at Drxlink International Pharmacist Association (since 2024) and Designated Partner at Omnivex Pharma Llp (since 2024).

DIN 10862077
Primary Designation Director
First Appointment 04 Dec 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Dec 20242024Active
Designated Partner04 Dec 20242024Active

Directorship timeline

Open interactive timeline →
Drxlink International Pharmacist Association
Omnivex Pharma Llp
Premium access

Shareholding and investment profile for Sarfraj Ahmad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sarfraj Ahmad

Sarfraj Ahmad currently holds 2 directorships: Drxlink International Pharmacist Association (Director, since 31 Dec 2024); Omnivex Pharma Llp (Designated Partner, since 04 Dec 2024).

Sarfraj Ahmad was first appointed on 04 Dec 2024 as Designated Partner at Omnivex Pharma Llp.

The current boards of Sarfraj Ahmad's companies include Anuj Kumar (Drxlink International Pharmacist Association), Shamsher Ahamad (Drxlink International Pharmacist Association), Vinita Gautam (Drxlink International Pharmacist Association), Rehan Ahmad (Omnivex Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available